In the March 2026 edition of MedTech Strategist, next-generation start-ups are examined for tackling heart failure as a systemic condition by harnessing natural physiological pathways. Ventric Health is featured prominently for its FDA-cleared Vivio device, which brings noninvasive early heart failure detection to primary care — identifying elevated filling pressures in both HFrEF and HFpEF patients before symptoms fully emerge.